nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0696	0.0834	CbGpPWpGaD
Succinylcholine—CHRNG—midbrain—Gilles de la Tourette syndrome	0.0333	0.202	CbGeAlD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.022	0.0264	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0219	0.0263	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0217	0.026	CbGpPWpGaD
Succinylcholine—CHRNG—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0214	0.0256	CbGpPWpGaD
Succinylcholine—CHRNE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0201	0.0241	CbGpPWpGaD
Succinylcholine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0188	0.0225	CbGpPWpGaD
Succinylcholine—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0187	0.0224	CbGpPWpGaD
Succinylcholine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0185	0.0222	CbGpPWpGaD
Succinylcholine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0182	0.0218	CbGpPWpGaD
Succinylcholine—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0182	0.0218	CbGpPWpGaD
Succinylcholine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.018	0.0216	CbGpPWpGaD
Succinylcholine—CHRNB1—midbrain—Gilles de la Tourette syndrome	0.017	0.103	CbGeAlD
Succinylcholine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.017	0.0203	CbGpPWpGaD
Succinylcholine—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0169	0.0203	CbGpPWpGaD
Succinylcholine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0168	0.0201	CbGpPWpGaD
Succinylcholine—CHRNG—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0164	0.0196	CbGpPWpGaD
Succinylcholine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0158	0.0189	CbGpPWpGaD
Succinylcholine—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0157	0.0188	CbGpPWpGaD
Succinylcholine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0156	0.0187	CbGpPWpGaD
Succinylcholine—CHRNE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0154	0.0184	CbGpPWpGaD
Succinylcholine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0153	0.0184	CbGpPWpGaD
Succinylcholine—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0153	0.0183	CbGpPWpGaD
Succinylcholine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0151	0.0181	CbGpPWpGaD
Succinylcholine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0143	0.0171	CbGpPWpGaD
Succinylcholine—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0142	0.017	CbGpPWpGaD
Succinylcholine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0141	0.0169	CbGpPWpGaD
Succinylcholine—CHRNA1—brain—Gilles de la Tourette syndrome	0.0139	0.084	CbGeAlD
Succinylcholine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0119	0.0142	CbGpPWpGaD
Succinylcholine—CHRND—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0119	0.0142	CbGpPWpGaD
Succinylcholine—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0119	0.0142	CbGpPWpGaD
Succinylcholine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0117	0.0141	CbGpPWpGaD
Succinylcholine—CHRNB1—brain—Gilles de la Tourette syndrome	0.0107	0.0648	CbGeAlD
Succinylcholine—CHRNA1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0101	0.0121	CbGpPWpGaD
Succinylcholine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.01	0.012	CbGpPWpGaD
Succinylcholine—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00997	0.0119	CbGpPWpGaD
Succinylcholine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00987	0.0118	CbGpPWpGaD
Succinylcholine—CHRND—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00911	0.0109	CbGpPWpGaD
Succinylcholine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00898	0.0544	CbGeAlD
Succinylcholine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00865	0.0523	CbGeAlD
Succinylcholine—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00831	0.00996	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00823	0.00986	CbGpPWpGaD
Succinylcholine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00817	0.0495	CbGeAlD
Succinylcholine—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00807	0.00967	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00799	0.00958	CbGpPWpGaD
Succinylcholine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.00787	0.0476	CbGeAlD
Succinylcholine—CHRNA1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00775	0.00928	CbGpPWpGaD
Succinylcholine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.00731	0.0443	CbGeAlD
Succinylcholine—BCHE—midbrain—Gilles de la Tourette syndrome	0.00726	0.044	CbGeAlD
Succinylcholine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00704	0.0426	CbGeAlD
Succinylcholine—CHRM2—brain—Gilles de la Tourette syndrome	0.00686	0.0415	CbGeAlD
Succinylcholine—CHRM1—brain—Gilles de la Tourette syndrome	0.00625	0.0378	CbGeAlD
Succinylcholine—BCHE—nervous system—Gilles de la Tourette syndrome	0.00597	0.0361	CbGeAlD
Succinylcholine—BCHE—central nervous system—Gilles de la Tourette syndrome	0.00575	0.0348	CbGeAlD
Succinylcholine—CHRM3—brain—Gilles de la Tourette syndrome	0.00559	0.0338	CbGeAlD
Succinylcholine—BCHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0053	0.00635	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00527	0.00631	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00522	0.00625	CbGpPWpGaD
Succinylcholine—BCHE—brain—Gilles de la Tourette syndrome	0.00456	0.0276	CbGeAlD
Succinylcholine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00442	0.0053	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.0043	0.00515	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00406	0.00486	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.004	0.00479	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00385	0.00462	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00374	0.00448	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00362	0.00434	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00361	0.00433	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00358	0.00429	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00352	0.00421	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00351	0.0042	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00349	0.00418	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00347	0.00416	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00339	0.00406	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00328	0.00393	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00327	0.00391	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00323	0.00388	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0031	0.00372	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00309	0.00371	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00306	0.00367	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00301	0.00361	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.003	0.0036	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00298	0.00356	CbGpPWpGaD
Succinylcholine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00297	0.00356	CbGpPWpGaD
Succinylcholine—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00296	0.00355	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.00294	0.00352	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00281	0.00336	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0028	0.00335	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00277	0.00332	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00266	0.00318	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00265	0.00317	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00236	0.00283	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00236	0.00282	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00233	0.0028	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0023	0.00275	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0023	0.00275	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00229	0.00274	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00229	0.00274	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00227	0.00271	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00227	0.00271	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00226	0.00271	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00214	0.00256	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00213	0.00255	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00211	0.00253	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00197	0.00236	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00196	0.00235	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00194	0.00233	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0015	0.00179	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00149	0.00179	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00148	0.00177	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00134	0.0016	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00133	0.0016	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00132	0.00158	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0013	0.00155	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00129	0.00155	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00128	0.00153	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00121	0.00145	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00121	0.00145	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00121	0.00145	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0012	0.00144	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0012	0.00143	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00119	0.00143	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00118	0.00141	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00117	0.00141	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00116	0.00139	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0011	0.00131	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00109	0.00131	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00108	0.0013	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000846	0.00101	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000844	0.00101	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000835	0.001	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000768	0.000921	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000766	0.000918	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000759	0.000909	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000717	0.000859	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000714	0.000856	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000708	0.000848	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000696	0.000833	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000694	0.000831	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000687	0.000823	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000648	0.000776	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000646	0.000774	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00064	0.000766	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000454	0.000544	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000453	0.000542	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000448	0.000537	CbGpPWpGaD
